Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Evaluating the Efficacy and Safety of HRS-1780 Tablets in Patients with CKD: TH-PO1189
用户wEPMgFb_HJo8
1小时前
8
10
求助中
帖子自动结束时间: 2026-10-19 09:48:27
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
Z Liu, H Zhang, X Li, D Zheng, G Bi, Z Ye…
Journal of the …, 2025
journals.lww.com
… HRS-1780 is a selective non-steroidal MRA in development. This study aimed to evaluate the
efficacy and safety of HRS-1780 … 1:1:1 to the HRS-1780 10 mg, 20 mg and placebo groups. …

